Volume 21, Number 2—February 2015
Research
Naturally Acquired Antibodies against Haemophilus influenzae Type a in Aboriginal Adults, Canada
Table 1
Group | No. | Age, y |
No. (%) female | No. (%) ≥60 y | |||
---|---|---|---|---|---|---|---|
Mean | Median | SD | Range | ||||
Aboriginal CRF patients | 30 | 54 | 54 | ±13.4 | 29–78 | 21 (70) | 10 (33) |
Aboriginal healthy comparison group | 30 | 49.1 | 47 | ±9.4 | 39–75 | 25 (83) | 4 (13) |
Non-Aboriginal CRF patients | 30 | 60.3 | 64.5 | ±13.9 | 26–79 | 11 (37) | 20 (67) |
Non-Aboriginal healthy comparison group | 30 | 58.7 | 56 | ±9.4 | 45–80 | 18 (60) | 11 (37) |
Healthy Aboriginal adults | 70 | 37.1 | 33.5 | ±12.7 | 19–75 | 58 (83) | 4 (6) |
Healthy non-Aboriginal adults | 70 | 41.3 | 43 | ±14.1 | 22–68 | 44 (63) | 7 (10) |
*CRF, chronic renal failure. No significant age difference between healthy Aboriginal and non-Aboriginal adults (p = 0.067), Aboriginal and non-Aboriginal CRF patients (p = 0.081), Aboriginal CRF patients and Aboriginal healthy comparison group (p = 0.11), non-Aboriginal CRF patients and non-Aboriginal healthy comparison group (p = 0.60), p<0.05 between Aboriginal and non-Aboriginal healthy comparison groups (p = 0.0002). Healthy comparison groups (n = 30) were drawn from the large group of healthy adults (n = 70).
Page created: January 20, 2015
Page updated: January 20, 2015
Page reviewed: January 20, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.